Search results for "Sarcopenia"

showing 10 items of 159 documents

Lower limb muscle strength and muscle mass are associated with incident symptomatic knee osteoarthritis: a Longitudinal Cohort Study

2021

Recent literature suggests that sarcopenia, often represented by low lower limbs muscle mass and strength, can be considered a potential risk factor for knee osteoarthritis (OA), but the available literature is still limited. We therefore aimed to investigate whether sarcopenia is associated with a higher risk of radiographic (ROA) and symptomatic knee OA (SxOA) in a large cohort of North American people in the context of the OA initiative. Sarcopenia at baseline was diagnosed in case of low skeletal muscle mass (i.e., lower skeletal mass index) and poor performance in the chair stands test. The outcomes of interest for this study included ROA (radiographical osteoarthritis) if a knee devel…

MaleSarcopeniaEndocrinology Diabetes and MetabolismDiseases of the endocrine glands. Clinical endocrinologyCohort Studiesolder peoplesarcopeniaEndocrinologyRisk Factorsosteoarthritis of the kneeOsteoarthritisepidemiology; muscle mass and function; older people; osteoarthritis of the knee; sarcopenia; Aged; Body Composition; Cohort Studies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Muscle Strength; Muscle Skeletal; Osteoarthritis Knee; Risk Factors; Sarcopenia; United StatesHumansKneeLongitudinal StudiesMuscle StrengthMuscle Skeletalmuscle mass and functionOriginal ResearchAgedddc:616SkeletalOsteoarthritis KneeMiddle AgedRC648-665musculoskeletal systemUnited StatesBody CompositionMuscleFemaleepidemiologyepidemiology muscle mass and function older people osteoarthritis of the knee Aged Body Composition Cohort Studies Female Humans Longitudinal Studies Male Middle Aged Muscle Strength Muscle Skeletal Osteoarthritis Knee Risk Factors Sarcopeniahuman activities
researchProduct

The association between sedentary behavior and sarcopenia among adults aged ≥65 years in low-and middle-income countries

2020

The present study aimed to assess the association between sedentary behavior and sarcopenia among adults aged &ge

MaleSarcopeniaHealth Toxicology and Mutagenesis[SDV]Life Sciences [q-bio]lcsh:MedicineWORLD-HEALTH-ORGANIZATIONLogistic regressionContinuous variableolder adult0302 clinical medicineMedicine030212 general & internal medicineGaitPublic Environmental & Occupational HealthLow- and middle-income countriesHand StrengthSedentary behaviormusculoskeletal system3. Good healthPREVALENCETIMEOBESITYOlder adultsIncome/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemaleLife Sciences & Biomedicinemedicine.medical_specialtyEnvironmental Sciences & EcologyArticleOddsSKELETAL-MUSCLE MASS03 medical and health sciencesSDG 3 - Good Health and Well-beingHumansOLDER-ADULTSAgedScience & Technologybusiness.industryPublic healthlcsh:RPublic Health Environmental and Occupational Healthmedicine.diseasebody regionsSedentary behaviorPHYSICAL-ACTIVITYCross-Sectional StudiesSocioeconomic FactorsAgeingLow and middle income countriesFATSarcopeniaSedentary Behaviorbusinesshuman activities030217 neurology & neurosurgeryEnvironmental SciencesDemographylow- and middle-income countries older adults sarcopenia sedentary behavior
researchProduct

The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter?

2019

BACKGROUND & AIMS Sarcopenia has emerged as a prognostic parameter in numerous cancer entities. Current research favours its role as a determining factor for overall survival (OS) in patients with intrahepatic cholangiocarcinoma (ICC); however, it is unclear whether sarcopenia is a truly independent survival predictor if combined with established prognostic factors. METHODS Between 1997-2018, 417 patients with histopathologically confirmed ICC were referred to our centre, of whom 293 were included in this study. Cross-sectional imaging, laboratory examinations and histopathological reports were retrospectively analysed. Psoas muscle index (PMI) as easy-to-measure marker of sarcopenia was ca…

MaleSarcopeniamedicine.medical_specialtyGastroenterologyResectionCholangiocarcinoma03 medical and health sciences0302 clinical medicineRisk FactorsGermanyInternal medicinemedicineHumansIn patientIntrahepatic CholangiocarcinomaAgedPsoas MusclesRetrospective StudiesUnivariate analysisHepatologybusiness.industryCancerMiddle AgedPrognosismedicine.diseaseMagnetic Resonance ImagingSurvival AnalysisPredictive valueBile Duct Neoplasms030220 oncology & carcinogenesisSarcopeniaMultivariate AnalysisCohortFemale030211 gastroenterology & hepatologyTomography X-Ray ComputedbusinessLiver International
researchProduct

Validation of bioelectrical impedance analysis for estimating limb lean mass in free-living Caucasian elderly people

2017

Background & aims Aging is characterized by a loss of limb lean mass (LLM) that can lead to physical disability and death. Regional bioelectrical impedance analysis (BIA) may be a reliable method for estimating LLM, but no prediction equations are available for elderly Caucasian subjects. The aim of this study was to develop and validate a BIA-based equation for predicting LLM in healthy elderly Caucasians, taking dual X-ray absorptiometry (DXA) as the reference method. Methods Using a cross-sectional design, 244 free-living healthy Caucasian subjects (117 men, 179 women) over 60 years of age were enrolled. LLM was measured with DXA (LLMDXA), and the resistance (Rz) and reactance (Xc) o…

MaleSarcopeniamedicine.medical_specialtyUrology030209 endocrinology & metabolismCritical Care and Intensive Care MedicineBody weightWhite PeopleNOBody Mass Index03 medical and health sciences0302 clinical medicineAbsorptiometry PhotonmedicineElectric ImpedanceElderly peopleHumans030212 general & internal medicineMuscle SkeletalSarcopenia Body composition Prediction equation Limb lean mass Older adultsAgedMultiple regression equationAged 80 and overNutrition and Dieteticsbusiness.industryBody WeightReproducibility of ResultsHealthy elderlyLimb lean massMiddle Agedmedicine.diseaseResistive indexPrediction equationCross-Sectional StudiesOlder adultsSarcopeniaLean body massPhysical therapyBody CompositionBody composition; Limb lean mass; Older adults; Prediction equation; Sarcopenia; Critical Care and Intensive Care Medicine; Nutrition and DieteticsFemalebusinessBioelectrical impedance analysis
researchProduct

Impact of Sarcopenia on Clinical Outcomes of Patients Undergoing Simultaneous Liver and Kidney Transplantation: A Cohort Study

2021

International audience; Background: The impact of sarcopenia in patients undergoing simultaneous liver and kidney transplantation (SLKT) has not been fully delineated. The aim of this single-centre-cohort-study was to evaluate the impact of sarcopenia on the clinical outcomes. Methods: Between 2003 and 2018, 79 patients underwent SLKT. Sarcopenia was assessed via the total psoas muscle area (TPA) at the level of the 3rd. lumbar vertebra. Sarcopenia threshold was TPA < 1460 mm2 (women) and <1560 mm2 (men). We identified post-operative biliary, vascular and digestive complications. Survival analysis was performed by the Kaplan Meier method (log-rank test). Results: We included 43/79 SLK…

MaleSarcopeniamedicine.medical_specialtymedicine.medical_treatment[SDV]Life Sciences [q-bio]Liver transplantationCohort Studies03 medical and health sciences0302 clinical medicineRenal DialysisInternal medicinemedicineHumansKidney transplantationDialysisHepatologybusiness.industryGastroenterologyPostoperative complicationMiddle Agedmedicine.diseaseKidney TransplantationLiver TransplantationTransplantationTreatment Outcome030220 oncology & carcinogenesisSarcopeniaCohortFemale030211 gastroenterology & hepatologybusinessCohort study
researchProduct

Sarcopenic obesity: definition, cause and consequences.

2008

PURPOSE OF REVIEW: Older obese persons with decreased muscle mass or strength are at special risk for adverse outcomes. We discuss potential pathways to muscle impairment in obese individuals and the consequences that joint obesity and muscle impairment may have on health and disability. Tantamount to this discussion is whether low muscle mass or, rather, muscle weakness should be used for the definition. RECENT FINDINGS: Excess energy intake, physical inactivity, low-grade inflammation, insulin resistance and changes in hormonal milieu may lead to the development of so-called 'sarcopenic obesity'. It was originally believed that the culprit of age-related muscle weakness was a reduction in…

Malemedicine.medical_specialtyAgingHealth StatusMedicine (miscellaneous)ComorbidityvanheneminenArticlesarcopeniaLow muscle massPhysical medicine and rehabilitationSDG 3 - Good Health and Well-beingClassification of obesityRisk FactorsmedicineHumansSarcopenic obesitysarkopeniaMuscle StrengthObesityExercise physiologyMuscle SkeletalExerciseAgedNutrition and Dieteticsbusiness.industryagingMuscle weaknessmedicine.diseaseComorbidityObesityMuscular AtrophyikääntyminenSarcopenia/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalemedicine.symptombusinessCurrent Opinion in Clinical Nutrition and Metabolic Care
researchProduct

Growth hormone replacement therapy prevents sarcopenia by a dual mechanism: improvement of protein balance and of antioxidant defenses.

2013

The aim of our study was to elucidate the role of growth hormone (GH) replacement therapy in three of the main mechanisms involved in sarcopenia: alterations in mitochondrial biogenesis, increase in oxidative stress, and alterations in protein balance. We used young and old Wistar rats that received either placebo or low doses of GH to reach normal insulin-like growth factor-1 values observed in the young group. We found an increase in lean body mass and plasma and hepatic insulin-like growth factor-1 levels in the old animals treated with GH. We also found a lowering of age-associated oxidative damage and an induction of antioxidant enzymes in the skeletal muscle of the treated animals. GH…

Malemedicine.medical_specialtyAgingSarcopeniaIGF-1. Mitochondrial biogenesis Myostatin p70S6KHormone Replacement TherapyMyostatinProtein degradationmedicine.disease_causeAntioxidantsInternal medicineMedicineAnimalsRats WistarMuscle Skeletalbiologybusiness.industryProtein turnoverSkeletal muscleProteinsmedicine.diseaseMitochondria MuscleRatsSomatropinEndocrinologymedicine.anatomical_structureMitochondrial biogenesisSarcopeniaGrowth Hormonebiology.proteinBody CompositionGeriatrics and GerontologybusinessOxidative stressThe journals of gerontology. Series A, Biological sciences and medical sciences
researchProduct

Effects of Leucine Administration in Sarcopenia: A Randomized and Placebo-controlled Clinical Trial

2020

Treating sarcopenia in older individuals remains a challenge, and nutritional interventions present promising approaches in individuals that perform limited physical exercise. We assessed the efficacy of leucine administration to evaluate whether the regular intake of this essential amino acid can improve muscle mass, muscle strength and functional performance and respiratory muscle function in institutionalized older individuals. The study was a placebo-controlled, randomized, double-blind design in fifty participants aged 65 and over (ClinicalTrials.gov identifier NCT03831399). The participants were randomized to a parallel group intervention of 13 weeks&rsquo

Malemedicine.medical_specialtyBODY-COMPOSITIONrespiratory muscles030209 endocrinology & metabolismPhysical exerciselcsh:TX341-641MASSPlaceboOBSTRUCTIVE PULMONARY-DISEASEelderlyArticlesarcopenia03 medical and health sciencesDOUBLE-BLIND0302 clinical medicineDouble-Blind MethodLeucineInternal medicineSTRENGTHRespiratory musclemedicineMUSCLE PROTEIN-SYNTHESISHumansAMINO-ACIDS030212 general & internal medicineVITAMIN-D SUPPLEMENTATIONEssential amino acidAgedchemistry.chemical_classificationAged 80 and overNutrition and Dieteticsbusiness.industryWHEY-PROTEINmedicine.diseaseClinical trialnutritionchemistrymuscle massSarcopeniaLean body massmuscle strengthFemaleLeucinePHYSICAL PERFORMANCEbusinesslcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct

Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults

2015

Background & aims: Aging is characterized by a loss of appendicular skeletal muscle mass (ASMM) leading to physical disability and death. Bioelectrical impedance analysis (BIA) is reliable in estimating ASMM but no prediction equations are available for elderly Caucasian subjects. The aim of the study was to develop and validate an equation derived from bioelectrical impedance analysis (BIA) to predict appendicular skeletal muscle mass (ASMM) in healthy Caucasian elderly subjects, taking dual X-ray absorptiometry (DXA) as the reference method, and comparing the reliability of the new equation with another BIA-based model developed by Kyle etal. (Kyle UG, Genton L, Hans D, Pichard C, 200…

Malemedicine.medical_specialtyCritical Care and Intensive Care MedicineWhite PeopleBody Mass IndexAbsorptiometry PhotonInternal medicineElectric ImpedanceHumansMedicineDual x-ray absorptiometryMuscle SkeletalAgedAged 80 and overMultiple regression equationNutrition and Dieteticsbusiness.industryBody WeightReproducibility of ResultsMiddle AgedSarcopeniaBody compositionPrediction equationLimbs lean massOlder adultsmedicine.diseaseSkeletal muscle massResistive indexSurgeryCross-Sectional StudiesSarcopeniaBody CompositionLinear ModelsLean body massCardiologyFemalebusinessBioelectrical impedance analysisClinical Nutrition
researchProduct

Sarcopenia, Diet, Physical Activity and Obesity in European Middle-Aged and Older Adults: The LifeAge Study

2021

The revised European consensus defined sarcopenia as a progressive and generalized skeletal muscle disorder that is associated with an increased likelihood of adverse outcomes including falls, fractures, physical disability and mortality. The aim of this study was to determine the prevalence of sarcopenia and analyse the influence of diet, physical activity (PA) and obesity index as risk factors of each criteria of sarcopenia. A total of 629 European middle-aged and older adults were enrolled in this cross-sectional study. Anthropometrics were assessed. Self-reported PA and adherence to the Mediterranean diet were evaluated with the Global Physical Activity Questionnaire (GPAQ) and Preventi…

Malemedicine.medical_specialtyPhysical disabilityMediterranean dietphysical condition030209 endocrinology & metabolismlcsh:TX341-641ArticleBody Mass Indexolder peoplesarcopenia03 medical and health sciences0302 clinical medicineInternal medicinemedicineAnimalsHumansMass indexMuscle StrengthObesity030212 general & internal medicineRisk factorMuscle Skeletaldietary habits; muscle mass; older people; physical condition; sarcopenia; sarcopeniadietary habitsAgedAged 80 and overNutrition and DieteticsAnthropometryHand Strengthbusiness.industryMiddle AgedAnthropometrymusculoskeletal systemmedicine.diseaseObesityDietbody regionsCross-Sectional Studiesmuscle massSarcopeniaRed meatFemaleRabbitsbusinessChickenshuman activitieslcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct